Cybin (CYBN.NE) announced today that it has closed its previously announced overnight marketed offering including the exercise in full of the over-allotment option granted to the Underwriters. “Investor demand…
Robertson
Ardelyx (ARDX.Q) announced today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Company’s New Drug Application (NDA) for…
ERYTECH Pharma (ERYP.Q) announced today that the U.S. Food and Drug Administration (FDA) has granted eryaspase Fast Track designation for the treatment of acute lymphocytic leukemia (ALL) patients who…
NanoVibronix (NAOV.Q) announced today that the Therapeutic Goods Administration (TGA), the Australian Regulatory body for Therapeutic Devices, has granted approval for the Company’s UroShield to be used by patients…
Cocrystal Pharma (COCP.Q) announced today that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed potent in vitro activity against the SARS-CoV-2 Delta and Gamma variants. “These in vitro SARS-CoV-2…
Filament Health (FH.NEO) announced today that it has been granted an amendment to its existing Health Canada Dealer’s License, bolstering the Company’s position at the forefront of natural psychedelic…
The Valens Company (VLNS.T), a leading manufacturer of cannabis products, announced today that it has signed a two-year agreement with Harvest One Cannabis. “Our partnership with The Valens Company…
Lexaria Bioscience (LEXX.Q) announced today that its DehydraTECH™ technology has been embraced by consumer brands and is now available for sale in over 7,000 stores across the US. “Lexaria’s…
Diagnos (ADK.V), a leader in early detection announced today that it has signed a pilot in Spain with three franchisees from Opticalia Group. “The campaign begins with the request…
Lexaria Bioscience (LEXX.Q) announced today that dosing has been completed for its HYPER-H21-2 study, the Company’s second human clinical study of 2021. Hypertension, also known as high blood…